Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis

Journal of Hepatology

Volumn 62, Issue 2, 2015, Pages 405-411

  Bril, Fernando ^a,b   Maximos, Maryann ^a,b   Portillo Sanchez, Paola ^a,b   Biernacki, Diane ^a,b   Lomonaco, Romina ^a,b   Subbarayan, Sreevidya ^a,b   Correa, Mark ^a   Lo, Margaret ^b,c   Suman, Amitabh ^b   Cusi, Kenneth ^a,b,d,e  

^a UNIVERSITY OF FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Diabetes; Fatty liver; Hepatic steatosis; Hydroxyvitamin D; NAFLD; NASH; Obesity

Indexed keywords

25 HYDROXYVITAMIN D; INSULIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; VITAMIN D;

ADULT; AGED; ARTICLE; BODY FAT; CONTROLLED STUDY; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ADOLESCENT; BIOPSY; COMPLICATION; DISEASE COURSE; FOLLOW UP; GLUCOSE BLOOD LEVEL; LIVER; METABOLISM; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOPSY; BLOOD GLUCOSE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN RESISTANCE; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PROGNOSIS; SEVERITY OF ILLNESS INDEX; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84922227008     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.08.040     Document Type: Article

References (38)

1. Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE, et al. Blood 25- hydroxy vitamin D levels and incident type 2 diabetes: A meta-analysis of prospective studies. Diabetes Care 2013; 36: 1422-1428.
2. Al Mheid I, Patel RS, Tangpricha V, Quyyumi AA. Vitamin D and cardiovascular disease: Is the evidence solid? Eur Heart J 2013; 34: 3691-3698.
3. Tomson J, Emberson J, Hill M, Gordon A, Armitage J, Shipley M, et al. Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12,000 deaths. Eur Heart J 2013; 34: 1365-1374.
4. Jablonski KL, Jovanovich A, Holmen J, Targher G, McFann K, Kendrick J, et al. Low 25-hydroxyvitamin D level is independently associated with nonalcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2013; 23: 792-798.
5. Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S, et al. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med 2011; 9: 85.
6. Liangpunsakul S, Chalasani N. Serum vitamin D concentrations and unexplained elevation in ALT among US adults. Dig Dis Sci 2011; 56: 2124-2129.
7. Seo JA, Eun CR, Cho H, Lee SK, Yoo HJ, Kim SG, et al. Low vitamin D status is associated with non-alcoholic Fatty liver disease independent of visceral obesity in Korean adults. PLoS One 2013; 8: E75197.
8. Armstrong MJ, Adams LA, Canbay A, Syn WK. Extrahepatic complications of non-alcoholic fatty liver disease. Hepatology 2014; 59: 1174-1197.
9. Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, et al. The nonskeletal effects of vitamin D: An Endocrine Society scientific statement. Endocr Rev 2012; 33: 456-492.
10. Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, Gerstein HC, et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 2010; 33: 1379-1381.
11. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820-825.
12. Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 2003; 88: 157-161.
13. Danziger J, Biggs ML, Niemi M, Ix JH, Kizer JR, Djousse L, et al. Circulating 25- hydroxyvitamin D is associated with insulin resistance cross-sectionally but not longitudinally in older adults: The Cardiovascular Health Study. Metabolism 2013; 62: 1788-1794.
14. Manco M, Calvani M, Nanni G, Greco AV, Iaconelli A, Gasbarrini G, et al. Low 25-hydroxyvitamin D does not affect insulin sensitivity in obesity after bariatric surgery. Obes Res 2005; 13: 1692-1700.
15. Grimnes G, Figenschau Y, Almas B, Jorde R. Vitamin D insulin secretion, sensitivity, and lipids: Results from a case-control study and a randomized controlled trial using hyperglycemic clamp technique. Diabetes 2011; 60: 2748-2757.
16. de las Heras J, Rajakumar K, Lee S, Bacha F, Holick MF, Arslanian SA. 25- Hydroxyvitamin D in obese youth across the spectrum of glucose tolerance from normal to prediabetes to type 2 diabetes. Diabetes Care 2013; 36: 2048-2053.
17. Kwok RM, Torres DM, Harrison SA. Vitamin D and non-alcoholic fatty liver disease (NAFLD): Is it more than just an association? Hepatology 2013; 58: 1166-1174.
18. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142: 1592-1609.
19. Lomonaco R, Ortiz-Lopez C, Orsak B, Finch J, Webb A, Bril F, et al. Role of ethnicity in overweight and obese patients with non-alcoholic steatohepatitis. Hepatology 2011; 54: 837-845.
20. Lomonaco R, Ortiz-Lopez C, Orsak B, Webb A, Hardies J, Darland C, et al. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with non-alcoholic fatty liver disease. Hepatology 2012; 55: 1389-1397.
21. Ortiz-Lopez C, Lomonaco R, Orsak B, Finch J, Chang Z, Kochunov VG, et al. Prevalence of prediabetes and diabetes and metabolic profile of patients with non-alcoholic fatty liver disease (NAFLD). Diabetes Care 2012; 35: 873-878.
22. Bril F, Lomonaco R, Orsak B, Ortiz-Lopez C, Webb A, Tio F, et al. Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with non-alcoholic steatohepatitis. Hepatology 2014; 59: 2178-2187.
23. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37: S81-S90.
24. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: Prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288: E462-E468.
25. Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 2003; 52: 2461-2474.
26. Sanyal AJ, Brunt EM, Kleiner DE, Kowdley KV, Chalasani N, Lavine JE, et al. Endpoints and clinical trial design for non-alcoholic steatohepatitis. Hepatology 2011; 54: 344-353.
27. Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: A trial sequential meta-analysis. Lancet Diabetes Endocrinol 2014; 2: 307-320.
28. Freedman BI, Register TC. Effect of race and genetics on vitamin D metabolism, bone and vascular health. Nat Rev Nephrol 2012; 12: 459-466.
29. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 2004; 89: 1196-1199.
30. Alvarez JA, Ashraf A. Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010; 2010: 351385.
31. Lind L, Hanni A, Lithell H, Hvarfner A, Sorensen OH, Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middleaged men. Am J Hypertens 1995; 8: 894-901.
32. Tai K, Need AG, Horowitz M, Chapman IM. Glucose tolerance and vitamin D: Effects of treating vitamin D deficiency. Nutrition 2008; 24: 950-956.
33. de Boer IH, Tinker LF, Connelly S, Curb JD, Howard BV, Kestenbaum B, et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care 2008; 31: 701-707.
34. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30: 980-986.
35. Li L, Zhang L, Pan S, Wu X, Yin X. No significant association between vitamin D and non-alcoholic fatty liver disease in a Chinese population. Dig Dis Sci 2013; 58: 2376-2382.
36. Catena C, Cosma C, Camozzi V, Plebani M, Ermani M, Sechi LA, et al. Nonalcoholic fatty liver disease is not associated with vitamin D deficiency in essential hypertension. High Blood Press Cardiovasc Prev 2013; 20: 33-37.
37. Ryan CK, Johnson LA, Germin BI, Marcos A. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl 2002: 1114-1122.
38. Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2007; 17: 517-524.